The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: Variation between label dosage and real-world use

1. Martinez-Cutillas, J.
2. Alerany-Pardo, C.
3. Borrás-Blasco, J.
4. Broto-Sumalla, A.
5. Burgos-Sanjosé, A.
6. Climent-Bolta, C.
7. Escudero-Vilaplana, V.
8. Fernández-Fuente, M.A.
9. Ferrit-Martin, M.
10. Gómez-Germá, P.
11. Martnez-Sesmero, J.M.
12. Mayorga-Pérez, J.
13. Menchén-Viso, B.
14. Merino-Alonso, J.
15. Polache-Vengud, J.
16. Sánchez-Guerrero, A.